Point72 Asset Management, L.P. reports

Company location: Stamford, CT
Fiscal year end: 31 December

Point72 Asset Management, L.P. has filed 1,033 SEC EDGAR filings since 08 Apr 2014

Filter by type:
SC13D
SC13G

SEC filing history

Showing 1-25 of 709 matching filings.

Per page

25

Current page

1

SC 13G/A

TERNS PHARMACEUTICALS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

COGENT BIOSCIENCES, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SPHERE ENTERTAINMENT CO.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

JOYY INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

AGENUS INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

HUYA INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

FOX CORPORATION

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ABEONA THERAPEUTICS INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SAGIMET BIOSCIENCES INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CRINETICS PHARMACEUTICALS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MEDIWOUND LTD.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SUTRO BIOPHARMA, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

KORRO BIO, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ITERUM THERAPEUTICS PLC

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

VENTYX BIOSCIENCES, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

LUMENTUM HOLDINGS INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

C4 THERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

SC 13G/A filing

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

MORPHIC HOLDING, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

HEALTH CATALYST, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

CYBIN INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A

ARCUTIS BIOTHERAPEUTICS, INC.

Filing date: 14 Nov 2024
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .